Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice (Q43610292)

25 November 2017

title

Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice (English)

1 reference

25 November 2017

1 reference

Jiang X

1 reference

25 November 2017

Namura S

series ordinal

1 reference

25 November 2017

Nagata I

series ordinal

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

305

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

41-44

1 reference

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Matrix metalloproteinases increase very early during experimental focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Matrix metalloproteinases in cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Ischemic cerebral edema and the blood-brain barrier. Distributions of pertechnetate, albumin, sodium, and antipyrine in brains of cats after occlusion of the middle cerebral artery

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Proteolytic cascade enzymes increase in focal cerebral ischemia in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901800-6

7 January 2021

10.1016/S0304-3940(01)01800-6

Identifiers

DOI

1 reference

25 November 2017

1 reference